MGZ 0.00% 2.0¢ medigard limited

Dixon's report 30 Oct - re cure for "patent's" with back...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 34 Posts.

    Dixon's report 30 Oct - re cure for "patent's" with back problems - Kt009. Why wasn't this reported in Bishop's annual report only 4 days earlier - lack of communication or some other reason ?

    Re Dixon's exciting new product announcement - the combination of two, old unproven products/ideas has failure written all over it - syringe patent 2006 - Kt009 patent 2007 (syringe only a drawing with a number) - not much of a choice out of the seventy odd products they assessed. I can't see this happening in my lifetime. 

 
watchlist Created with Sketch. Add MGZ (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.